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79Programmatic colorectal cancer (CRC) screening increases uptake, but the design and resources
utilized for such models are not well known. We characterized program components and
participation at each step in a large program that used mailed fecal immunochemical testing
(FIT) with opportunistic colonoscopy.80
81METHODS:82Mixed-methods with site visits and retrospective cohort analysis of 51-75-year-old adults









93Among 1,023,415 screening-eligible individuals, 405,963 (40%) were up to date with screening
at baseline, and 507,401 of the 617,452 not up-to-date were mailed a FIT kit. Of the entire
cohort (n [ 1,023,415), 206,481 (20%) completed FIT within 28 days of mailing, another
61,644 (6%) after a robocall at week 4, and 40,438 others (4%) after a mailed reminder letter
at week 6. There were over 800,000 medical record screening alerts generated and about
295,000 FIT kits distributed during patient office visits. About 100,000 FIT kits were ordered
during direct-to-patient calls by medical assistants and 111,377 people (11%) completed FIT
outside of the automated outreach period. Another 13,560 (1.3%) completed a colonoscopy,
sigmoidoscopy, or fecal occult blood test unrelated to FIT. Cumulatively, 839,463 (82%) of those
eligible were up to date with screening at the end of the year and 12,091 of 14,450 patients
(83.7%) with positive FIT had diagnostic colonoscopy.94
95CONCLUSIONS:96
97The >82% screening participation achieved in this program resulted from a combination of
prior endoscopy (40%), large initial response to mailed FIT kits (20%), followed by smaller
responses to automated reminders (10%) and personal contact (12%).98
99Keywords: Colorectal Cancer Screening; Fecal Immunochemical Tests; Mailed Fecal Tests.100aThese authors contributed equally.
Abbreviations used in this paper: COVID-19, coronavirus disease 2019;
CRC, colorectal cancer; FIT, fecal immunochemical testing; KPNC, Kaiser
Permanente Northern California.


















116Most deaths from colorectal cancer (CRC) arepreventable with screening, but many eligible
people are not up-to-date on screening.1,2 In 2006, Kaiser
Permanente Northern California (KPNC) began an orga-
nized program of annual mailed fecal immunochemical
testing (FIT) combined with opportunistic colonoscopy.
That approach increased screening dramatically: the pro-
portion of its members up-to-date with screening
doubled from about 40% to more than 80%,3,4 accompa-
nied by a 52% decrease in CRC mortality.3 Health sys-
tems wishing to replicate this approach lack detailed
information about the program components and
required resources. Prior reports noted that extensive
service delivery infrastructure (eg, program management
and quality assurance activities) and navigation staffFLA 5.6.0 DTD  YJCGH57525_proof were needed to increase screening uptake,5 multiple
methods of outreach and in-reach increased screening
participation, and multicomponent approaches were
more effective than individual components.6 Screening
outreach has become more important with precipitous
drops in uptake because of the coronavirus disease
2019 (COVID-19) pandemic. However, few studies have17 November 2020  9:29 pm  ce




















































































































232examined the specific program components, resources
required, and screening outcomes of simultaneous use
of multiple strategies in a well-defined population to
serve as a model for informing such approaches.7
We sought to characterize the program components,
resources needed, and incremental participation at each
step in the screening process over a 1-year period (2017)
in an established KPNC program that primarily uses




The study used a mixed methods sequential explan-
atory design to assess increases in CRC screening uptake
with a population-based programmatic approach. We
thus evaluated screening program quantitative data in
tandem with qualitative data including direct ethno-
graphic observations of screening processes. The KPNC
Institutional Review Board approved this study and
waived the requirement for individual informed consent.
Setting
We used data from KPNC, a large integrated health
care delivery organization with 15 health service areas
that serve approximately 4.5 million members in urban,
suburban, and semirural regions in California. Each ser-
vice area has its own leadership, primary care offices,
and gastroenterology departments. KPNC’s members are
similar sociodemographically to the rest of Northern
California, except at extremes of income, but are less
likely to have >5 doctor visits per year or report being in
poor health.8
Screening Program
Overviews of the CRC screening program have been
published previously.3,9,10 Before 2006, KPNC relied on
visit-based physician requests for CRC screening (ie,
opportunistic screening), predominantly using flexible
sigmoidoscopy and guaiac fecal occult blood tests.
Following pilot testing in 2006, KPNC established a
direct-to-patient annual mailed FIT outreach program for
those not up to date with screening, without the need for
a face-to-face office visit. Screening up to date was
defined as receipt of colonoscopy within 10 years,
sigmoidoscopy within 5 years, or FIT within the same
calendar year. Completed tests are analyzed by an
automated OC-Sensor Diana (Polymedco Inc, Cortland
Manor, NY) with a cutoff level of >20 mg hemoglobin per
gram of stool for a positive result. Patients with a posi-
tive test are directed to have follow-up colonoscopy.
Screening colonoscopy in place of FIT is available by
request.FLA 5.6.0 DTD  YJCGH57525_proof Framework
The overall FIT-based screening program involves 6
core functions: (1) central management of FIT-based
screening, (2) automated FIT outreach, (3) local FIT
outreach, (4) local FIT in-reach, (5) central processing of
completed FIT kits, and (6) local follow-up of FIT results.
Data Collection
We began by creating detailed process maps of the
entire FIT-based CRC screening program, from the
identification of those due for screening, to the comple-
tion of diagnostic colonoscopies for those with positive
tests. This required a review of program components and
site visits to primary care offices, gastroenterology de-
partments, and the regional laboratory. Data collection
methods included field notes, ethnographic observations,
and interviews with program leaders. Centralized FIT
outreach activities were determined at the regional level
(across all of KPNC); however, for greater granularity, we
measured local outreach and in-reach activities in a
single KPNC service area; although some details of in-
reach differ between service areas, global resource use
is similar across service areas. Staff positions were
described using job titles (eg, clinical lead, project man-
ager) and training level (eg, physician, medical assistant).
Screening Cohort
We identified a cohort of KPNC health plan members
who were CRC screening-eligible in 2017, as defined
earlier. The program targets people who are due for
screening and are 51–75 years old on December 31 of
each calendar year.
Statistical Analyses
For the quantitative analysis, we summarized the
cohort characteristics and the percentages of people who
were eligible for screening and completed each step of
the screening process. We also examined the percentages
who were mailed a FIT kit, completed a FIT (after initial
outreach, robocall reminder, mailed reminders, and




Central management of fecal immunochemical
testing–based screening: Oversight of the CRC screening
program was ensured by a population health manage-
ment team including a part-time clinical leader (physi-
cian), full-time lead project manager, part-time data
analyst health educator, and a part-time operations17 November 2020  9:29 pm  ce
Figure 1. Delivery of centralized, automated FIT outreach, local outreach, and local in-reach in 2017. Eligible people are
identified by the Patient Reminder, Outreach Management, Population Tracking (PROMPT) system. At 56 days after the FIT kit
mailing, the names of nonresponders are transferred to responsible primary care practices for local outreach. Local outreach
occurs primarily within 5 weeks of transfer. All FIT completed in 2017 that were not within 91 days of a FIT mailing were
assumed to be caused by local FIT in-reach.




















































































































348manager. This group managed all automated outreach
and provided assistance and materials to the service
areas. They often test changes to outreach procedures in
parallel with existing procedures (A/B testing), and only
proceed to widespread implementation if they observe
increases in FIT completion. They were supported by theFLA 5.6.0 DTD  YJCGH57525_proof Information Technology Division, which maintains a Pa-
tient Reminder, Outreach Management & Population
Tracker (PROMPT) system and the Population Health
Management Division, which coordinates all population-
level preventive activities. PROMPT was developed by
KPNC as a custom-built add-on to the EPIC-based17 November 2020  9:29 pm  ce




















































































































464electronic health record system. A Consumer Report
Services group manages approximately 800–1000 com-
plaints and questions annually (primarily people ineli-
gible for FIT or requesting a new FIT kit). A
communications department regularly updates informa-
tion materials (materials available on request).
Automated fecal immunochemical testing outreach:
Prenotices, automated FIT kit mailings, and the coordi-
nation of robocall and letter reminders were performed
by an outside vendor (Figure 1). Each year, the PROMPT
system identifies people eligible for FIT outreach. Let-
ters are then mailed near the anniversary of the prior
year’s FIT completion date, or birthday or half birthday
for those who had not completed FIT previously. The
vendor sends preletters (touch 1) to eligible individuals
1 week before the arrival of mailed FIT kits (touch 2).
The FIT kit includes information materials personalized
with the primary care provider, pictorial instructions,
and a prepaid envelope addressed to a central labora-
tory. Four weeks after mailing the FIT kits, a robocall
(touch 3) with interactive voice response is made, and
after 6 weeks, a reminder letter (touch 4) is sent to
nonrespondents. These automated steps are tailored for
those identified as Black or Hispanic; the communica-
tions department created paper information materials
with messages that resonated more strongly with these
groups during a series of focus groups. Active users of
an online patient portal receive electronic messages (ie,
e-Alert) 3 days before mailings and are only sent a
reminder letter by mail if the electronic message is not
opened.
Local fecal immunochemical testing outreach: The
names of nonrespondents are automatically sent to their
primary care office 8 weeks after FIT mailings for further
local follow-up. Medical assistants make telephone calls
or send partially personalized electronic messages or
mailings when possible (touch 5) to nonrespondents to
complete and return the test. This activity occurs pri-
marily between 8 and 13 weeks after the automated
processes to minimize redundancy.
Local fecal immunochemical testing in-reach:
Throughout the year, those ages 51–75 who attend office
visits and are not up to date with screening may receive
reminders and be offered a FIT kit (in-reach) at the visit.
The PROMPT system alerts medical assistants during the
“rooming” process, showing which step of the outreach
process has been completed, allowing staff to, if possible,
leverage upcoming delivery of FIT kits rather than hand
out additional kits in the office. If the patient cannot
recall receiving a mailed FIT kit and no record exists of a
completed test, a kit is given to the patient at the time of
the visit.
Laboratory processing of completed fecal immuno-
chemical testing kits: Whether received by mail or in-
person, all tests were completed at home and
returned in prepaid envelopes to a designated central
laboratory where staff review the contents for
completeness (Figure 2). Tests with no date or illegibleFLA 5.6.0 DTD  YJCGH57525_proof information were submitted to the laboratory’s Client
Services Department. If the information obtained
allowed further processing, the required test informa-
tion is manually entered into a laboratory database, an
order placed, and a label generated for subsequent
automated processing. If the test cannot be processed, a
new FIT kit is mailed to the member with an explana-
tion of the error. Laboratory technicians load specimens
onto automated analyzers, with a maximum processing
speed of 250 tests per hour. Analyses were repeated for
all borderline positive results (between 18 and 20 mg/
g), with the highest result retained. Specimens with >14
days between collection and receipt are analyzed and
referred to Client Services if negative; given that stool
hemoglobin concentrations decline over time, negative
results >14 days old trigger a request for a new test
and are not reported.
Local follow-up of fecal immunochemical testing re-
sults: Negative test results are sent electronically to pa-
tients and primary care providers in addition to a
postcard to patients (Figure 3). All positive results are
posted in PROMPT. Primary care providers or their staff
contact patients individually to explain the need for
diagnostic colonoscopy and make an electronic referral
to the gastroenterology department. Each primary care
department has a medical assistant assigned to track
results. In most cases, gastroenterology departments
have a designated nurse practitioner or similar who en-
sures follow-up of patients with a positive FIT, in addi-
tion to a designated medical assistant scheduler who
contacts patients each day to explain the colonoscopy
procedure and schedule appointments. In some areas,
this staff member calls members with a positive FIT
result directly, without waiting for primary care
referral.11 Patients scheduled for colonoscopy are given a
prescription and standardized instructions for bowel
preparation to be picked up from the local pharmacy. All
FIT-positive colonoscopies are considered preventive
examinations, and therefore have no or limited
copayments.
For negative examinations (ie, no biopsy), the endo-
scopist adds to the patient’s medical record an indication
for “average-risk screening in 10 years.” For positive
colonoscopy examinations (ie, polyp or mass), the
endoscopist enters “pending pathology results.” Once
pathology results are available, the relevant guideline-
recommended rescreening or surveillance interval is
entered into PROMPT. If the lesion was cancerous, the
primary care provider is notified, and an e-referral is
made to a colorectal surgeon. Referral is made to medical
oncology if stage IV disease is found.
A system-wide goal was set for 80% of patients with a
positive FIT to be reached by telephone and complete
their colonoscopy (if indicated) within 28 days of the
positive test. Primary care and gastroenterology de-
partments receive regular performance reports about
screening up-to-date and colonoscopy follow-up status
for FIT-positive patients, respectively.17 November 2020  9:29 pm  ce
Figure 2. Central processing and analysis of completed FIT. QC, quality control.



































































































563Screening Participation in the 2017 Cohort
Of 1,237,448 KPNC health plan members who
were 51–75 years old in 2017, 1,023,415 (83%) were
continuously enrolled in 2016 and 2017 and were
included (Figure 1). In the beginning of 2017, 405,963
(40%) of the 1,023,415 were up to date with screening
from a prior colonoscopy or sigmoidoscopy. At the end of
the 2017 calendar year, a total of 839,463 (82%) mem-
bers were screening up to date. Compared with those
who completed screening, those who did not were
younger and less likely to have completed a FIT in 2016
(Table 1).
Outcomes of automated outreach: The screening
pathway and incremental participation for those eligible
for mailed FIT at the beginning of 2017 is shown in
Figure 1. A total of 507,401 were mailed a FIT kit and
206,481 (41%) completed the test within 4 weeks.
Among those eligible who were not mailed a kit, many
completed screening before their mail date, some had
previously refused participation, and others were
excluded because of serious illness (as documented by a
physician or because residing in a skilled nursing facility
or hospice). Of 300,920 members who received a robo-
call reminder at Week 4, 61,644 (20%) completed FIT,
and a further 40,438 (13%) completed the test within 2
weeks after a reminder letter. Almost all of those who
completed a FIT during the automated outreach had
completed a FIT the year prior (93%; Table 1). At this
point, through a combination of prior colonoscopy andFigure 3. Follow-up of FIT results, stratified by normal or “negati
mg/mL. GI, gastroenterology.
FLA 5.6.0 DTD  YJCGH57525_proof mailed outreach efforts, 70% of the population was
screening up to date.
Local outreach and in-reach: During local outreach to
nonresponders (n ¼ 198,838), primarily between 8 and
13 weeks after automated mailings, 42,753 (4.2%)
completed a FIT. A further 27,631 (2.7%) of those
mailed a FIT completed a test by the end of 2017,
presumably through local in-reach. Those who
completed a FIT or colonoscopy outside of the auto-
mated outreach were younger and less likely to have
completed a FIT the year prior than those who
responded to automated outreach (Table 1). In 2017,
more than 800,000 PROMPT patient alerts for CRC
screening occurred and nearly 295,000 additional FIT
kits were given directly to patients during clinic visits.
Approximately 100,000 additional FIT kits were or-
dered through direct-to-patient calls from medical as-
sistants. The central laboratory attempted to contact
approximately 18,000 members by telephone or secure
email to obtain missing information, allowing them to
process about half of these samples.
Follow-up for positive test results: Of the 419,940 pa-
tients who completed a FIT in 2017, 14,450 (3.4%) were
FIT-positive and 6203 (42%) received a colonoscopy
within 30 days of the result date and 11,738
(81%) within 6 months. Of those who received a colo-
noscopy within 1 year, 7301 (60%) had 1 adenoma
resected, 1028 (8.5%) had an advanced adenoma (ie,
advanced neoplasia on histology), and 335 (2.7%) were
diagnosed with CRC.ve” results 20 mg/mL and abnormal or “positive” results >20


















Table 1. Characteristics of Kaiser Permanente Northern California Cohort Members Ages 51–75 in 2017 With Continuous
Enrollment in 2016–2017, Stratified into 4 Groups Based on Screening Status at the Beginning of 2017 and the







of a mail date
Completed FIT or
colonoscopy at
another time in 2017
No documented
screening test by
end of 2017 Overall cohort
Total 405,963 308,563 124,937 183,952 1,023,415
Age, y
51–64 217,901 (54) 194,797 (63) 95,122 (76) 141,865 (77) 649,685 (63)
65–75 188,062 (46) 113,766 (37) 29,815 (24) 42,087 (23) 373,730 (37)
Sex
Male 191,368 (47) 143,750 (47) 56,796 (45) 89,538 (49) 481,451 (47)
Female 214,595 (53) 164,813 (53) 68,141 (54) 94,414 (51) 541,963 (53)
Race/ethnicity
Non-Hispanic White 236,467 (58) 166,967 (54) 64,100 (51) 91,318 (50) 558,852 (55)
Black 28,641 (7) 18,936 (6) 9169 (7) 13,950 (8) 70,696 (7)
Asian or Pacific Islander 64,050 (16) 62,187 (20) 22,924 (18) 28,288(15) 177,449 (17)
Hispanic 52,064 (13) 40,882 (13) 20,675 (17) 30,454 (17) 144,075 (14)
Other 18,530 (5) 11,257 (4) 4058 (3) 4539 (2) 38,384 (4)
Unknown 6211 (2) 8334 (3) 4011 (3) 15,403 (8) 33,959 (3)
Completed a FIT in 2016 86,302 (21) 286,179 (93) 76,566 (61) 46,659 (25) 495,706 (48)
NOTE. All values are n (%).
FIT, fecal immunochemical test.





















































































































In a population of more than 1 million people with a
40% screening rate at baseline, centralized, automated
outreach resulted in a 30 percentage point increase in
screening within 8 weeks. Subsequent clinic-based
outreach via personalized telephone calls and mes-
sages, and in-reach through visit-based reminders,
resulted in an additional 12 percentage point increase in
coverage, yielding an overall 82% screening participation
rate.
CRC screening rates in the United States are well
short of the 80% goal set by the National Colorectal
Cancer Round Table.2,12 Effective programs are needed
to increase uptake, particularly if expansion of lower
eligibility age is more widely adopted. Our study findings
are consistent with randomized trials showing that FIT
mailings provide a 28 percentage point increase in
screening compared with opportunistic screening
alone.13 In another meta-analysis, various types of pa-
tient navigation increased screening uptake by 17 per-
centage points, and patient reminders by 3 percentage
points,6 although inconsistent implementation can
diminish effectiveness.14 In a 4-arm randomized trial
that added automated electronic health record–linked
FIT mailings to usual care, then mailings, and finally
nurse navigation,15 each addition provided added
benefit: usual care to automated mailings increased
participation from 26% to 51%, with telephone assis-
tance increasing participation further to 58%, and navi-
gation to 65%, although that study required informedFLA 5.6.0 DTD  YJCGH57525_proof consent, limiting the representativeness of its partici-
pants. Our study shows that high rates of screening
completion can be achieved on a much larger scale
among a diverse, community-based population. The
proactive delivery of screening using opt-out principles
likely contributes to the high screening rates achieved.16
KPNC offered colonoscopy in addition to the mailed
program, which over time contributes to the high
screening rates. A potential pitfall of using multiple
strategies is overscreening (patients already up to date
who nonetheless complete a FIT). Anecdotally, over-
screening is rare because the electronic health record
add-on, PROMPT, is continuously updated across all
sites. However, the use of multiple outreach strategies
can create tension between providers and patients who
do not want CRC screening and resent repeated
reminders.
People can encounter multiple barriers to CRC
screening.12 Systematically mailing FIT without charge
along with reminders addresses multiple structural
barriers. However, potential participants often still ex-
press feelings of fear, negative past experiences with the
health system, and fatalism.17 In-person contact with a
trusted provider may explain why automated outreach
alone may not be sufficient for reaching screening rates
>80%. Repeat nonparticipants in the KPNC program are
less intrinsically motivated and more often disgusted by
stool collection for FIT.18 FIT outreach may be particu-
larly relevant with limitations in access to colonoscopy
and population fears of in-person visits because of
COVID-19.1917 November 2020  9:29 pm  ce










































































































802KPNC invested significant resources to track tests
with incomplete information and to ensure timely
completion of colonoscopy following positive FIT re-
sults.20 These quality criteria, often overlooked by
guidelines,21 are critical to effective screening. Additional
follow-up was necessary for 4% of tests received at the
laboratory, including 2% that could not be processed.
Error rates as high as 20% have been observed.22 The
fewer errors in the program studied may be caused by
automated processes including preprinted labels in
contrast to handwritten identifiers and dates. KPNC also
distributes illustrated (wordless) FIT instructions
created with input from patient focus groups, which has
decreased laboratory recall for specimens with incom-
plete data. KPNC investments in tracking systems, pa-
tient support and navigation resources, and endoscopy
capacity increased colonoscopy completion for positive
FIT within 30 days from 9% to 34% between the
2006–2008 period and 2013–2016.11
Strengths of this study include its mixed methods
approach to provide a complete picture of programmatic
CRC screening in a large, diverse population. A primary
study limitation is that we did not have a comparison
group or time-point to evaluate the precise effects of
implementing the various screening program compo-
nents described. However, several screening components
have been shown to be effective in smaller randomized
trials of a single intervention. Our results are from a
single, large integrated health system, which may limit
applicability for smaller programs or individual prac-
tices; however, many of the most effective elements (ie,
mailed outreach, and telephone reminders) are
commonly used. We do not have information about
reasons for nonparticipation; some members may have
made informed decisions not to be screened. Further-
more, we described an established program and did not
show the steps needed to build and launch the program.
Finally, precise cost information was not available
because of difficulty identifying true costs versus charges
and high variability in personnel costs across settings.
In conclusion, this study showed mailed FIT with
automated outreach and targeted personalized outreach
and in-reach increased screening participation to 82%.
Substantial resources were used for laboratory quality
control and the follow up of positive FIT. High-quality
CRC screening can be achieved on a large scale, but
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